JEBP

  • About
  • Journal’s Board
  • Submission and Instructions to Authors
  • Issues
  • News

COGNITIVE PROCESSING THERAPY VERSUS MEDICATION FOR THE TREATMENT OF COMORBID SUBSTANCE USE DISORDER AND POST-TRAUMATIC STRESS DISORDER IN EGYPTIAN PATIENTS (RANDOMIZED CLINICAL TRIAL)

Amani ElBarazi 1,2,3*, Osama A. Badary1,2,4, Mohamed M. Elmazar2,5, Hanan Elrassas6

amani.safwat@bue.edu.eg

1 Clinical Pharmacy Practice Department, Faculty of Pharmacy, The British University in Egypt, P.O. Box 43, El-Sherouk City, Cairo 11837, Egypt.
2 The Center for Drug Research and Development (CDRD), Faculty of Pharmacy, The British University in Egypt, P.O. Box 43, El-Sherouk City, Cairo 11837, Egypt.
3 Clinical Psychology Clinic, Safwat Elgolf Hospital, Almaza, Nasr City, Cairo, Egypt.
4 Clinical Pharmacy Practice Department, Faculty of Pharmacy, Ain Shams University, P.O. Box 11566, Abbasia, Cairo, Egypt.
5 Pharmacology and Biochemistry Department, Faculty of Pharmacy, The British University in Egypt, P.O. Box 43, El-Sherouk City, Cairo 11837, Egypt.
6 Neuropsychiatry Department, Faculty of Medicine, Ain Shams University, P.O. Box 11566, Abbasia, Cairo, Egypt.

Abstract

Earlier research has established that posttraumatic stress disorder (PTSD) and substance use disorder (SUD) frequently coexist. Aims: Cognitive Processing Therapy was compared to Sertraline and a placebo in an RCT for treating patients with comorbid SUD and PTSD. Methods: 150 patients with SUD and PTSD were interviewed by clinicians and asked to fill out the Clinician-Administered PTSD Scale (CAPS-5), Posttraumatic Stress Disorder Checklist (PCL-5), Beck Depression Inventory (BDI-II), Timeline Follow Back Interview (TLFB), and Brief Addiction Monitor (BAM). Patients were randomly assigned to the following conditions: CPT (n=50), Sertraline (n=50), or Placebo (n=50). Pretreatment, posttreatment, six and, twelve-month follow-up assessments were conducted. Results: When compared to the sertraline group, CPT resulted in much higher reductions in CAPS scores at posttreatment assessment (d=0.93, p < .000). When compared to the control group, CPT considerably reduced PTSD symptoms (the effect size, d=1.9, p < .000). Sertraline resulted in many significant decreases in CAPS when compared to control groups (the effect size , d=1.11, p<.000). At posttreatment, SUD and depression severity were significantly reduced in both CPT and Sertraline groups. After six and twelve months of follow-up, these differences persisted. Conclusion: Comparatively to the control group, CPT and Sertraline significantly decreased PTSD, SUD, and depression.

Please cite this article as: ElBarazi, A., Badary, O. A., Elmazar, M. M., & Elrassas, H. (2022). COGNITIVE PROCESSING THERAPY VERSUS MEDICATION FOR THE TREATMENT OF COMORBID SUBSTANCE USE DISORDER AND POST-TRAUMATIC STRESS DISORDER IN EGYPTIAN PATIENTS (RANDOMIZED CLINICAL TRIAL). Journal of Evidence-Based Psychotherapies, 22(2), 63-90.

DOI: 10.24193/jebp.2022.2.13

Published online: 2022/09/01
Published print: 2022/09/01

Keywords: Cognitive processing therapy, Sertraline, Posttraumatic stress disorder, Substance use disorder, Depression.

Full text – Cognitive Processing Therapy Versus Medication for the Treatment of Comorbid Substance Use Disorder and Post-Traumatic Stress Disorder in Egyptian patients (Randomized Clinical Trial) Download
Oct 14, 2022Carmen Cotet
THE CONVERGENT VALIDITY OF THE ROMANIAN VERSION OF THE BEHAVIORAL ASSESSMENT OF CHILDREN: A MULTITRAIT-MULTIMETHOD ANALYSISTHERAPEUTIC MECHANISM AND EFFECTIVENESS OF THE SINGLE-SESSION SUICIDE CRISIS INTERVENTION
Journal of Evidence-Based Psychotherapies

Journal of Evidence-Based Psychotherapies

Categories
  • Vol XIX, No.1, 2019 (9)
  • Vol XIX, No.2, 2019 (9)
  • Vol XX, No.1, 2020 (8)
  • Vol XX, No.2, 2020 (10)
  • Vol XXI, No. 1, 2021 (8)
  • Vol XXI, No. 2, 2021 (11)
  • Vol XXII, No.1, 2022 (9)
  • Vol XXII. No.2, 2022 (9)
  • Vol XXIII, No.1, 2023, Special Issue (8)
  • Vol XXIII, No.2, 2023 (9)
  • Vol XXIV, No.1, 2024, Special Issue (9)
  • Vol XXIV, No.2, 2024 (10)
  • Vol XXV, No. 1, 2025 (8)
  • Vol XVIII, No. 2, 2018 (10)
  • Vol XVIII, No. 1, 2018 (10)
  • Vol XVI, No. 2, 2016 (9)
  • About (7)
  • Vol XVII, No. 2, 2017 (10)
  • Vol XVII, No. 1, 2017 (9)
  • Vol XVI, No. 1, 2016 (9)
  • Vol XV, No. 2, 2015 (9)
  • Vol XV, No. 1, 2015 (12)
  • Vol XIV, No. 2, 2014 (13)
  • Vol XIV, No. 1, 2014 (7)
  • Vol XIII, No. 2, 2013 (13)
  • Vol XIII, Special Issue 2a, 2013 (11)
  • Vol XIII, Special Issue 1a, 2013 (7)
  • Vol XIII, No. 1, 2013 (8)
  • Vol XII, No. 2, 2012 (8)
  • Vol XII, No. 1, 2012 (9)
  • Vol XI, No. 2, 2011 (11)
  • Vol XI, No. 1, 2011 (8)
  • Vol X, No. 1, 2010 (9)
  • Vol IX, No. 2, 2009 (8)
  • Vol IX, No. 1, 2009 (9)
  • Vol VIII, No. 2, 2008 (11)
  • Vol VIII, No. 1, 2008 (9)
  • Vol VII, No. 2, 2007 (5)
  • Vol VII, No. 1, 2007 (7)
  • Vol VI, No. 2, 2006 (9)
  • Vol VI, No. 1, 2006 (8)
  • Vol V, No. 2, 2005 (7)
  • Vol V, No. 1, 2005 (6)
  • Vol IV, No. 2, 2004 (3)
Keywords
irrational beliefscbtrebtEditorialdistresscognitive-behavioral therapyappraisalcognitive restructuringschemasautism spectrum disordersbinary model of distressrational emotive behavior theoryconversion disorderautismhypnosispositive illusionstheory of mindearly interventioncommunicationdevelopmentthe Attitudes and Belief Scale 2incompatible information techniquedeficitsneural structurestoddlerscognitive psychologyrational anticipation techniquewithdrawal motivational systemsattributionsfunctional and dysfunctional negative emotionsunitary model of distressmind reading beliefsirrational and rational beliefstreatmenteating behavioursmental healtharousalpre-goal/ post-goal attainment positive emotionsfunctional and dysfunctional emotionscore relational themesapproach motivational systemsdemandingnessdysfunctional consequencesdysfunctional positive emotionspreferences
e-mail us:

jebpeditor@gmail.com

The International Institute for the Advanced Studies of Psychotherapy and Applied Mental Healt

http://psychotherapy.psiedu.ubbcluj.ro

2017 © Journal of Evidence-Based Psychotherapies